H-KLQCVDLHV-OH

Rif. 3D-PP46283

Informazioni sul prodotto

• Nome: H-KLQCVDLHV-OH
• Sinonimi: NH2-Lys-Leu-Gln-Cys-Val-Asp-Leu-His-Val-OH

Descrizione

Peptide H-KLQCVDLHV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KLQCVDLHV-OH include the following: NAR Breakthrough Article The Cancer Epitope Database and Analysis Resource ZK alo glu-Yalcın, N Blazeska, R Vita, H Carter - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/c636/0a7765a7cb73951ef7ca571e2b79ab47c51a.pdf The cancer epitope database and analysis resource (CEDAR) Z Koà ŞaloÄŞlu-Yalaca, N Blazeska , R Vita - Nucleic acids , 2023 - academic.oup.comhttps://academic.oup.com/nar/article-abstract/51/D1/D845/6761984 Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide S Perambakam, S Hallmeyer, S Reddy - Cancer Immunology , 2006 - Springerhttps://link.springer.com/article/10.1007/s00262-005-0090-x -Up of HLA-A2+ Patients with High-Risk, Hormone-Sensitive Prostate Cancer Vaccinated with the Prostate Specific Antigen Peptide Homologue (PSA146-154) S Perambakam, H Xie, S Edassery , DJ Peace - 2010 - academia.eduhttps://www.academia.edu/download/95904176/473453.pdf Follow-Up of HLA-A2+ Patients with High-Risk, Hormone-Sensitive Prostate Cancer Vaccinated with the Prostate Specific Antigen Peptide Homologue (PSA146-154 S Perambakam, H Xie , S Edassery - Journal of Immunology , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/full/10.1155/2010/473453 T cells expressing a TCR-like antibody selected against the heteroclitic variant of a shared MAGE-A epitope do not recognise the cognate epitope M Saeed , E Schooten, M van Brakel, D K. Cole - Cancers, 2020 - mdpi.comhttps://www.mdpi.com/2072-6694/12/5/1255 Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses M Nouri-Shirazi, J Banchereau , D Bell - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/7/3797/33524 Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor DV Tassev, M Cheng, NKV Cheung - Cancer gene therapy, 2012 - nature.comhttps://www.nature.com/articles/cgt201166 Prostate Tumor Antigen Discovery: Development of a Novel Genetic Approach DL Mann, MARYLAND UNIV BALTIMORE - 1999 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADB282266

• Marchio: Biosynth